Just some unbelievable facts screams a BUY:
Kala Pharmaceuticals Down Over 14%, on Pace for Largest Percent Decrease Since October 2018 --
12:35 pm ET October 27, 2020 (Dow Jones) Print
Kala Pharmaceuticals, Inc. (KALA) is currently at $6.61, down $1.11 or 14.38%
-- Would be lowest close since March 16, 2020, when it closed at $6.13
-- On pace for largest percent decrease since Oct. 3, 2018, when it fell 15.52%
-- Earlier Tuesday, Kala Pharmaceuticals announced the U.S. Food and Drug Administration has approved Eysuvis for the short-term treatment of the signs and symptoms of dry-eye disease. The company said Eysuvis is the first approved prescription therapy specifically for short-term treatment of the chronic, episodic disease that affects the tears and ocular surface
-- Currently down five of the past six days
-- Currently down three consecutive days; down 15.26% over this period
-- Worst three day stretch since the three days ending Sept. 24, 2020, when it fell 15.77%
-- Down 11.87% month-to-date
-- Up 79.13% year-to-date; on pace for best year on record (Based on available data back to July 20, 2017)
-- Down 75.08% from its all-time closing high of $26.53 on Sept. 14, 2017
-- Up 89.94% from 52 weeks ago (Oct. 29, 2019), when it closed at $3.48
-- Down 52.07% from its 52-week closing high of $13.79 on June 2, 2020
-- Up 89.94% from its 52-week closing low of $3.48 on Oct. 29, 2019
-- Traded as low as $6.07; lowest intraday level since March 17, 2020, when it hit $5.04
-- Down 21.37% at today's intraday low; largest intraday percent decrease since Jan. 5, 2018, when it fell as much as 31.85%
